Our technology is designed to enable clinicians to apply thermotherapy treatment to the precise site of the tumor.
The Sensius system is a technology platform. With the system, different body site applicators will be available in the future. The body applicators can be connected to the FocusCore, that produces the microwaves. The body applicator directs the microwaves to the tumor by the antennas in the applicator, which are controlled by the FocusControl software.
The first applicator is for the treatment of Head and Neck Cancer. A prototype is already in use in Erasmus MC (Rotterdam, NL). The prototype is now in the transition to a commercial product. We aim for market launch early 2024.
The second applicator is for the treatment of intact breast cancer. This will be released early 2025 for clinical evaluation.
In addition, our technology is also made to optimize the treatment outcome and enables a choice to balance the outcome and quality of life.